Diagnóstico Precoce Autismo Brasil: ciRS-7 UFRGS | AcademicJobs
Pesquisadores da UFRGS e HCPA identificam biomarcador promissor para diagnóstico precoce do TEA, superando desafios atuais no Brasil.

No reviews yet. Be the first to rate Carmem!
Carmem Gottfried is a titular professor in the Department of Biochemistry at the Universidade Federal do Rio Grande do Sul (UFRGS). She earned a pharmacy degree from the Universidade Federal de Santa Maria in 1991, a master’s degree in biochemistry from UFRGS in 1996, and a doctorate in biological sciences (biochemistry) from UFRGS in 2000, including a sandwich scholarship period at the University of Newcastle in Australia. She completed postdoctoral training at the Institut du Fer à Moulin, INSERM-UPMC, Sorbonne Université in France from 2014 to 2015.
Since joining UFRGS in 2005 as an associate professor, Gottfried has served as head of the Research Group in Neuroglial Plasticity and as a member of the Translational Research Group in Autism Spectrum Disorder (GETTEA) at the Hospital de Clínicas de Porto Alegre. She has held leadership roles in the Postgraduate Program in Neuroscience, including director from 2013 to 2014 and vice-director from 2009 to 2013. Her research focuses on autism spectrum disorders using translational approaches that combine basic science and clinical studies, including animal models induced by valproic acid, preventive strategies such as resveratrol, and investigations into neuroglial plasticity and related molecular mechanisms. Gottfried is a productivity fellow of the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and a founding member of the Autism Wellbeing And Research Development (AWARD) Initiative. She has authored book chapters on topics including antipsychotics in autism treatment and valproic acid as an animal model for autism spectrum disorder, and she coordinates extension projects such as Art and Neuroscience that produce educational materials for children. She has received recognition as an honored professor by graduates in biomedical sciences.
Professional Email: null
Pesquisadores da UFRGS e HCPA identificam biomarcador promissor para diagnóstico precoce do TEA, superando desafios atuais no Brasil.